Shire to Present Scientific Data and Research Findings on ADHD Treatments at ... MarketWatch (press release) "We believe that the Vyvanse and INTUNIV study findings will be an important contribution to the current collection of ADHD research. ... and more »

Shire to Present Scientific Data and Research Findings on ADHD Treatments at ... PR Newswire (press release) "We believe that the Vyvanse and INTUNIV study findings will be an important contribution to the current collection of ADHD research. ... and more »

The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye - where it can treat that common disease- almost 100 times longer than possible with current commercial lenses, scientists reported here today. At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® ...

Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% FOXBusiness VYVANSE, our leading ADHD treatment with a current monthly US ADHD market share of 13.6%, continues to grow and build strong brand recognition in the US and ...